Gottlieb says vaccination “should be a backstop” to protect against virus variant – CBS News

Washington — Dr. Scott Gottlieb, who once helmed the Food and Drug Administration (FDA), said Sunday that COVID-19 vaccines “should be a backstop” against a new coronavirus variant detected in the United Kingdom that has now been identified in the United States.

“The good news with B.1.1.7, if there is good news, is that as we vaccinate more of the population, it should be a backstop against the continued spread of that variant,” Gottlieb said of the U.K. strain in an interview with “Face the Nation.” 

New coronavirus variants have been identified in the U.K., South Africa and Brazil and are now circulating globally, according to the Centers for Disease Control and Prevention. The U.K. variant, B.1.1.7., has been reported in 30 states, while the South African variant, B.1.351, and Brazilian variant, P.1, have been reported in South Carolina and Minnesota, respectively.

Gottlieb said there is evidence to suggest the U.K. strain causes more severe illness and is roughly 50% more transmissible, but he noted that data from COVID-19 vaccine trials from Johnson & Johnson and Novavax, which are both developing coronavirus vaccine, shows immunization and prior infection appear to be protective against the variant.

“Prior immunity and the vaccines do appear to be as effective against this new variant,” he said. “So as we immunize more of the population and if people continue to wear masks and be vigilant in these parts of the country, we can keep this at bay. It’s not too late, but it’s a real risk to those regions of the country right now.”

Gottlieb predicted there could be booster shots to protect against the variants for the fall and said the FDA is working on a regulatory framework to allow for the vaccine boosters to be licensed.

“I think that framework is going to be mapped out and the companies have said they’re already working on those new boosters. We could have them in time for the fall across all these vaccines. There’s no reason we can’t do that,” he said.

Gottlieb said it’s unlikely there will be a national epidemic with B.1.1.7 in the spring and summer, though the fall does pose a risk. Instead, he predicted there will be regionalized epidemics, with California and South Florida the current hotspots. There are 113 reported cases of the U.K. variant in California and 125 reported cases in Florida, according to the CDC.

“Those cities need to be very mindful of the spread of these variants,” he said.

There have been more than 26 million confirmed coronavirus cases in the U.S. and nearly 440,000 deaths, according to Johns Hopkins University. But the Biden administration is warning the death toll will surpass 500,000 and projecting another 90,000 Americans will die from COVID-19 in the next four weeks.

Still, hospitalizations and the spread of COVID-19 appear to be declining

Gottlieb said the nation has “the potential to turn a corner,” but acknowledged the new variants create risk.

“Things are clearly improving around the country,” he said. “We can’t take our foot off the brake too quickly in terms of the things that people are doing, like wearing masks and being more vigilant. That’s really probably what’s bringing down infection rates across the country right now.”


COVID-19 vaccines effective against current variants, but new one may prove more difficult, Inglesby says – Fox News

Dr. Tom Inglesby, Director of the Center for Health Security of the Johns Hopkins Bloomberg School of Public Health, said Sunday that while COVID-19 vaccines continue to prove effective against the current variants, this might not continue to be the case if more variants emerge.

Inglesby downplayed concerns about recently discovered variants, particularly the South Africa variant which has reportedly displayed resistance to some treatments and possibly the vaccine itself.

“What we’re seeing is that in the variant that was found in South Africa, at least in mild to moderate disease, some of the vaccine studies are showing diminished effectiveness,” Inglesby confirmed to “Fox News Sunday” host Chris Wallace, while noting that “we still have enough cushion with the vaccines that they will still be very effective at this point.”

Dr. Tom Inglesby, Director of the Bloomberg School of Public Health at the Johns Hopkins Center for Health Security, speaks during a briefing on the developments of the novel coronavirus, also known as COVID-19, from medical and research staff from Johns Hopkins University on Capitol Hill on March 6, 2020 in Washington, D.C. (Photo by Samuel Corum/Getty Images)

Dr. Tom Inglesby, Director of the Bloomberg School of Public Health at the Johns Hopkins Center for Health Security, speaks during a briefing on the developments of the novel coronavirus, also known as COVID-19, from medical and research staff from Johns Hopkins University on Capitol Hill on March 6, 2020 in Washington, D.C. (Photo by Samuel Corum/Getty Images)

Inglesby warned, however, that “it’s a message that’s saying this virus is evolving and could continue to evolve in ways that make it more dangerous – either more transmissible or more lethal.”

Inglesby praised the Johnson & Johnson vaccine, however, saying that it was an “amazing” development that provides a much-needed boost as the country pushes to vaccinate more people in an aggressive campaign.


He also suggested that trials for the Johnson & Johnson vaccine accounted for the new variants – an element for which the earlier Pfizer and Moderna vaccines could not have tested – and that might have factored into the Johnson & Johnson vaccine’s lower efficacy.

The vaccine also appears to improve in efficacy as time goes on, reaching potentially 85% protection against all strains after 28 days.

The vaccine could help push schools to re-open. Experts point to “community prevalence” as the most important factor when considering whether or not to re-open schools, and more vaccines will help drive down that prevalence.


“As long as the community prevalence of the disease around them is not overwhelming,” Inglesby said about school reopening. “And so that’s really encouraging news, but what we see is that schools that have resources can put those things in place, and many schools in the country have not been able to put those things into place.”


Not Yet Desperate, Japan and South Korea Plod Toward Vaccinations – The New York Times

TOKYO — Japan’s biggest cities are under a state of emergency as coronavirus deaths rise, even while the country tries to convince the world it can safely hold the Summer Olympics. South Korea is prohibiting gatherings of five or more people to keep a recent surge in cases under control. Hong Kong imposed stringent lockdowns on some of its poorest neighborhoods to stop an uptick.

And yet none of these places have begun to carry out the only solution with any hope of putting the pandemic behind them: vaccinations.

While the United States and most nations in Europe as well as the Asian behemoths China and India have begun inoculating their populations, Japan, South Korea and Hong Kong have stood out by proceeding much more slowly.

Japan will not even begin to vaccinate medical workers — those at the front of the line — until the end of February. The same is true in South Korea, and those over 65 will not start receiving inoculations until May. Hong Kong, a semiautonomous territory of China, will begin vaccinating “high risk” groups in the middle of February.

To a certain extent, the three East Asian economic powerhouses have the luxury of time. Despite recent increases in infections, they have not experienced the kinds of outbreaks that have devastated the United States or Britain. The three governments say that they will approve vaccines after standard regulatory reviews and that they are laying the logistical groundwork for a smooth rollout.

“Japan, South Korea and Hong Kong are in the enviable position that their strong application of public health controls and preventions has allowed them to strongly control the disease burden,” said Dr. Krishna Udayakumar, director of the Duke Global Health Innovation Center. “So it’s not vaccination or nothing. The countries that are feeling a more urgent need to accelerate vaccinations are those that are suffering most.”

The delays, which come as more contagious and perhaps deadlier variants of the virus are emerging around the globe, could hamper these governments’ efforts to protect the public and restore normalcy for their weary populations.

But postponement also offers opportunities. The laggards can take the time to learn from the troubled rollouts in the United States and Europe, where supply problems, challenges with refrigeration and debates over who to inoculate first have dogged the vaccine campaigns.

By moving more deliberately, the East Asian governments may also be able to alleviate some concerns among the public about the remarkable speed with which the vaccines have been created. In Japan and South Korea, polls show that many people are reluctant to get vaccinated right away.

“The bottlenecks are really going to be on the demand side,” Dr. Udayakumar said. “Can we actually convince people to accept the vaccine and can we roll out implementation quickly enough to reach herd immunity through vaccinations?”

Supply, too, may restrain the speed of the rollout. While Hong Kong approved Pfizer’s vaccine in January, neither Japan nor South Korea has approved any yet. Both countries have contracts with multiple vaccine makers for enough doses to cover more than their entire populations. Manufacturers are scrambling to fill these orders and many others.

“If vaccines are secured, South Korea will proceed in vaccination quicker than any other countries in the world, and this is what South Korea is good at,” said Kim Woo-joo, an infectious disease specialist at Korea University. “The problem is that it is uncertain and not guaranteed that the vaccines will arrive at the right time.”

In theory, Japan has a more urgent deadline. The government is insisting that it will proceed with the Olympics despite intensifying questions about the feasibility of doing so. The Games, which were originally scheduled for 2020 in Tokyo but postponed to this summer, are scheduled to open on July 23.

In January, Thomas Bach, president of the International Olympic Committee, encouraged athletes, Olympic officials and others likely to travel to Tokyo for the Games “to get vaccinated in their home countries, in line with national immunization guidelines, before they go to Japan.”

But vaccination will not be required, officials have said. In comments about the Olympics before the Japanese Parliament in January, Prime Minister Yoshihide Suga said that “by taking proper measures against infection, we are preparing to hold a safe and secure tournament without having a vaccine as a prerequisite.”

That has spurred worries in Japan that large numbers of unvaccinated people could be arriving this summer. In turn, those traveling to Japan to compete might feel more confident if local residents have been vaccinated in large numbers.

Even as these pressures build, there have been signs that the government is lowering expectations for a speedy distribution schedule. This past week, Taro Kono, a cabinet minister appointed to manage coronavirus vaccinations, said that residents over 65 would not start getting jabs until at least April. Herd immunity would most likely not come until months after the Olympics.

Another major potential complication for the Japanese government is a public that has demonstrated among the highest levels of skepticism about vaccines in the world. Misinformation, fueled by the media, has thwarted earlier campaigns.

After the human papillomavirus vaccine to prevent cervical cancer was introduced in Japan in 2010, local media widely reported that some girls who had been inoculated were suffering from side effects that experts later found had no connection to the vaccine.

Yet memories of those media reports — however vague — still influence public opinion.

Kazuo Inoue, 68, a semiretired consultant in Tokyo, said his attitude was “wait and see.”

“Generally, any new vaccine or new medicines have side effects,” he said. “And we had several cases before. I forgot the name of the vaccine, but it was a vaccine for girls, for HPV, a new one and it had a lot of side effects for many people.”

Erika Yamao, 33, a hairstylist and mother of three young children in Tokyo, said she had been watching midday talk shows where celebrity hosts warned about possible side effects of the vaccines. She said she was disinclined to get a shot when it became available.

Covid-19 Vaccines ›

Answers to Your Vaccine Questions

Currently more than 150 million people — almost half the population — are eligible to be vaccinated. But each state makes the final decision about who goes first. The nation’s 21 million health care workers and three million residents of long-term care facilities were the first to qualify. In mid-January, federal officials urged all states to open up eligibility to everyone 65 and older and to adults of any age with medical conditions that put them at high risk of becoming seriously ill or dying from Covid-19. Adults in the general population are at the back of the line. If federal and state health officials can clear up bottlenecks in vaccine distribution, everyone 16 and older will become eligible as early as this spring or early summer. The vaccine hasn’t been approved in children, although studies are underway. It may be months before a vaccine is available for anyone under the age of 16. Go to your state health website for up-to-date information on vaccination policies in your area

You should not have to pay anything out of pocket to get the vaccine, although you will be asked for insurance information. If you don’t have insurance, you should still be given the vaccine at no charge. Congress passed legislation this spring that bars insurers from applying any cost sharing, such as a co-payment or deductible. It layered on additional protections barring pharmacies, doctors and hospitals from billing patients, including those who are uninsured. Even so, health experts do worry that patients might stumble into loopholes that leave them vulnerable to surprise bills. This could happen to those who are charged a doctor visit fee along with their vaccine, or Americans who have certain types of health coverage that do not fall under the new rules. If you get your vaccine from a doctor’s office or urgent care clinic, talk to them about potential hidden charges. To be sure you won’t get a surprise bill, the best bet is to get your vaccine at a health department vaccination site or a local pharmacy once the shots become more widely available.

That is to be determined. It’s possible that Covid-19 vaccinations will become an annual event, just like the flu shot. Or it may be that the benefits of the vaccine last longer than a year. We have to wait to see how durable the protection from the vaccines is. To determine this, researchers are going to be tracking vaccinated people to look for “breakthrough cases” — those people who get sick with Covid-19 despite vaccination. That is a sign of weakening protection and will give researchers clues about how long the vaccine lasts. They will also be monitoring levels of antibodies and T cells in the blood of vaccinated people to determine whether and when a booster shot might be needed. It’s conceivable that people may need boosters every few months, once a year or only every few years. It’s just a matter of waiting for the data.

“I don’t know how much it can actually protect me,” Ms. Yamao said. “And there are a lot of risks associated with it.”

Government advisers say they will have to tread carefully with public health campaigns promoting the vaccines.

“I think that just asking people to get the vaccine will be a source of more backlash,” said Takashi Nakano, a professor at Kawasaki Medical School and a member of the health ministry’s advisory board on vaccines. “People may think, ‘Why is he suggesting I take the unsafe vaccine along with the government push?’”

In part to assuage domestic concerns, Pfizer, Moderna and AstraZeneca have been conducting small clinical trials in Japan in advance of obtaining regulatory approval for their vaccines. Japan has contracts with the three companies and recently announced plans to manufacture doses of the shot developed by AstraZeneca domestically.

Given the government push to host the Olympics, officials are particularly concerned about tethering an immunization campaign to the success of the Games.

“Vaccination and the Olympics should be separated,” Shunichi Shinkawa, an official in Japan’s Cabinet Secretariat Office for Novel Coronavirus Disease Control, said in an interview. “Vaccination is for the people and to protect human life in Japan.”

Even some athletes are wary. Mei Ichinose, a Paralympic swimmer who is competing for Japan and currently training near Brisbane in Australia, said she had been asked if she feared that the vaccine might affect her performance.

“Performance aside, I don’t know if I feel 100 percent safe to get it as just a human being,” she said. “Vaccines usually take a lot of time to be created,” she added. “But this time, the vaccines were made so quickly, so I worry about their safety.”

In other cases, decisions about whether to take the vaccine may just come down to whether it allows people to do something they really want.

Ms. Yamao, the Tokyo hairdresser, said she would be vaccinated if it meant she could visit her parents in Osaka.

“If I can’t ride the bullet train without the vaccine, then I would consider it,” she said. “It’s a last resort.”

Reporting was contributed by Youmi Kim from Seoul, South Korea, Tiffany May from Hong Kong and Makiko Inoue from Tokyo.


Infectious disease expert warns double-masking can do more harm – New York Post

A top infectious disease expert has warned that wearing two masks can “do more harm” if one of the face coverings isn’t being correctly worn.

Michael Osterholm, who was an advisor to President Joe Biden’s transition team, said that the problem occurs with masks that have an “already compromised fit or filtration capacity,” allowing respiratory droplets to escape out of holes.

“If you add on another mask, you may actually make it tougher for the air to move through the two-cloth area, and then at that point it causes more air to actually leak around the sides, which actually enhances your ability to get infected,” Osterholm told NBC anchor Chuck Todd on “Meet the Press” Sunday.

Osterholm said there are cases where double-masking can be an effective tool against the coronavirus.

“But at the same time, there are many [where] you may do more harm,” said the director of the Center for Infectious Disease Research and Policy at the University of Minnesota.

Osterholm said what’s “very important” to him is to stop people from wearing the mask under their nose.

“You know, that’s like fixing three of the five screen doors in your submarine,” he said.

“We’ve got to get people to start using these right, that would help right there tremendously,” he added.

White House coronavirus advisor Dr. Anthony Fauci has said two masks are “likely… more effective.”


BBB warns: Stop putting your coronavirus vaccine card on social media – WJW FOX 8 News Cleveland

Sorry, Readability was unable to parse this page for content.


Hawaii reports 3 new coronavirus-related deaths, 82 additional infections – Honolulu Star-Advertiser

Hawaii Department of Health officials today reported three new coronavirus-related deaths and 82 additional infections, bringing the state’s totals since the start of the pandemic to 410 fatalities and 25,853 cases.

Two of the latest deaths were on Oahu and the third was on Maui. No further details were immediately released on the fatalities.

The state’s official coronavirus-related death toll includes 327 fatalities on Oahu, 53 on Hawaii island, 26 on Maui, one on Kauai, and three Hawaii residents who died outside the state.

The U.S. coronavirus-related death toll was nearly 441,000 today.

Today’s new statewide infection cases reported by the Health Department include 59 on Oahu, 11 on the Big Island, eight on Maui, and four residents diagnosed outside of Hawaii, officials said.

The statistics released today reflect the new infection cases reported to the department on Friday.

>> RELATED STORY: Hawaii educators get a chance for COVID-19 vaccines

The total number of coronavirus cases by island since the start of the outbreak are 20,923 on Oahu, 2,162 in Hawaii County, 1,734 on Maui, 178 on Kauai, 107 on Lanai and 25 on Molokai. There are also 724 Hawaii residents diagnosed outside of the state. As a result of updated information, one case from Maui was re-categorized to Hawaii island, state officials said today.

Health officials also said today that of the state’s total infection count, 1,412 cases were considered to be active. Officials say they consider infections reported in the past 14 days to be a “proxy number for active cases.” The number of active cases in the state decreased by 44 today.

By island, Oahu has 1,040 active cases, Maui has 276, the Big Island has 90, Kauai has five, and Lanai has one, according to the state’s latest tally. Molokai has no active COVID cases.

Health officials counted 4,569 new COVID-19 test results in today’s tally, for a 1.7% statewide positivity rate. The state’s 7-day average positivity rate is 2.2%, according to the Hawaii COVID-19 Data dashboard.

Of all the confirmed Hawaii infection cases, 1,696 have required hospitalizations, with two new hospitalizations on Oahu reported today by state health officials.

Four hospitalizations in the statewide count are Hawaii residents who were diagnosed and treated outside the state. Of the 1,692 hospitalizations within the state, 1,484 have been on Oahu, 99 on Maui, 96 on the Big Island, seven on Kauai, five on Lanai and one on Molokai.

According to the latest information from the department’s Hawaii COVID-19 Data dashboard, a total of 75 patients with the virus were in Hawaii hospitals as of Friday morning, with 20 in intensive care units and 15 on ventilators.

Health officials said that as of Jan. 24, 106,654 vaccines have been administered of the 170,975 received by the state. The administered vaccinations by county are Honolulu, 68,521; Maui, 11,060; Hawaii, 10,459 and Kauai, 8,799. The total also included several thousand administered under the federal pharmacy program. State officials release the verified updated vaccination numbers each Wednesday.

Oahu moved to the less-restrictive Tier 2 of Honolulu’s four-tier economic recovery plan on Oct. 22. To gauge whether Honolulu will move to a different tier, the city takes a “weekly assessment” of two key COVID-19 numbers each Wednesday. To move to Tier 3 from Tier 2, the 7-day average of new cases must be below 50 on two consecutive Wednesdays. Also, the 7-day average positivity rate must be below 2.5% on those two Wednesdays.

Today’s seven-day average case count for Oahu is 70 and the seven-day average positivity rate is 2.6%, according to Honolulu Mayor Rick Blangiardi.

Blangiardi has said he hoped to stay in Tier 2, a four-tiered framework established by former Mayor Kirk Caldwell. Under Tier 3, social gatherings of up to 10 would be allowed, up from 5 under Tier 2, and retail businesses would be able to operate at full capacity, rather than 50% capacity under Tier 2.

This breaking news story will be updated as more information becomes available.


Maine sees fewest new coronavirus cases in months and no deaths – Bangor Daily News

Another 156 coronavirus cases have been reported across the state and no new deaths, Maine health officials said Sunday.

The number of coronavirus cases diagnosed in the past 14 days statewide is 5,765. This is an estimation of the current number of active cases in the state, as the Maine CDC is no longer tracking recoveries for all patients. That’s down from 5,949 on Saturday.

It was the smallest daily increase in coronavirus cases the state has seen since Nov. 15 when 149 cases were reported. That comes as Maine has seen a steady decline in the size of daily growth in confirmed virus transmission, a trend that has been mirrored nationally.

Still, Sunday’s report remains well above the level Maine saw prior to the surge in virus transmission that began in late October.

The statewide death toll remains at 590. It was the first time in the past week when Maine didn’t record at least one death.

Sunday’s report brings the total number of coronavirus cases in Maine to 39,324, according to the Maine Center for Disease Control and Prevention. That’s up from 39,168 on Saturday.

Of those, 31,689 have been confirmed positive, while 7,635 were classified as “probable cases,” the Maine CDC reported.

The new case rate statewide Sunday was 1.17 cases per 10,000 residents, and the total case rate statewide was 293.81.

Maine’s seven-day average for new coronavirus cases is 363, down from 367.3 a day ago, down from 455.1 a week ago and down from 479 a month ago. That rate has been steadily falling since Jan. 14, when it peaked at 625.6.

The most cases have been detected in Mainers in their 20s, while Mainers over 80 years old make up the majority of deaths. More cases and deaths have been recorded in women than men. For a complete breakdown of the age and sex demographics of cases, hospitalizations and deaths, use the interactive graphic below.

So far, 1,390 Mainers have been hospitalized at some point with COVID-19, the illness caused by the new coronavirus. Of those, 160 Mainers are currently hospitalized, with 52 in critical care and 29 on ventilators. Out of 391 critical care beds, 95 are currently available. Meanwhile, 224 out of 320 ventilators are available. Currently, 443 alternative ventilators are available.

The total statewide hospitalization rate on Sunday was 10.39 patients per 10,000 residents.

Cases have been reported in Androscoggin (4,313), Aroostook (1,141), Cumberland (11,197), Franklin (771), Hancock (779), Kennebec (3,113), Knox (578), Lincoln (471), Oxford (1,908), Penobscot (3,420), Piscataquis (203), Sagadahoc (776), Somerset (1,089), Waldo (512), Washington (622) and York (8,429) counties. Information about where an additional two cases were reported wasn’t immediately available.

For a complete breakdown of the county by county data, use the interactive graphic below.

An additional 4,397 Mainers have been vaccinated against the coronavirus in the past day. As of Sunday, 112,916 Mainers have been vaccinated against the coronavirus, with 38,407 who have received two doses.

New Hampshire reported 524 new cases on Sunday and six deaths. Vermont reported 173 new cases and one death, and Massachusetts reported 4,108 new cases and 87 deaths.

As of Sunday morning, the coronavirus had sickened 26,091,122 people in all 50 states, the District of Columbia, Puerto Rico, Guam, the Northern Mariana Islands and the U.S. Virgin Islands, as well as caused 440,094 deaths, according to the Johns Hopkins University of Medicine.

Nationwide, 30.5 million doses of the vaccine have been administered, according to Bloomberg.


1 new COVID-19 related death in Brazos County, 102 new cases reported – KBTX

BRYAN, Texas (KBTX) -The Brazos County Health District has reported 102 additional positive cases of COVID-19 in Brazos County. Currently, there are 1,523 active cases.

One new death has been reported in the last 24 hours. There have been 177 total deaths in Brazos County related to COVID-19.

13,908 patients are classified as recovered, which means they have been fever-free for 72 hours without fever-reducing medications, and it has been 10 days after onset of symptoms.

58% percent of the new confirmed cases are from the 18-24-year-old age group.

There have been 3,196 probable cases in Brazos County since June 18, 2020. A probable COVID-19 case is determined by a positive antigen test. Confirmed COVID-19 cases are determined by a positive PCR test. The health district conducts case investigations on all confirmed and probable cases.

There are currently 425 active probable cases and there have been 2,771 probable recovered cases.

The total number of confirmed positive cases in the county since testing began is 15,608. There have been 160,245 tests performed.

Brazos County’s total hospital bed occupancy is at 87 percent, and total ICU bed occupancy is at 129 percent.

Currently, there are 40 Brazos County residents hospitalized for COVID-19.

State Trauma Service Area N

Most of the Brazos Valley falls under state trauma service area N (Brazos, Burleson, Grimes, Leon, Madison, Robertson, and Washington counties). Trauma Service Area N currently reports 650 staffed hospital beds with 53 beds available. According to the state’s latest data, the region has 0 available ICU beds and 53 available ventilators. The state’s last update listed 88 lab-confirmed COVID-19 patients currently in the hospital.


County Active Cases Total Cases Recovered Cases Fatalities One Dose
Austin 81 1570 1,464 25 1733 288
Brazos 1523 15,608 13,908 177 8734 1594
Burleson 98 1178 1,055 25 755 212
Grimes 19 1958 1884 55 982 191
Houston 80 1437 1324 33 1274 228
Lee 155 1300 1109 36 594 109
Leon 59 914 822 33 522 129
Madison 49 1201 1129 23 362 104
Milam 60 1173 1113 33 1398 112
Montgomery 6040 39241 18338 211 10,988 5,051
Robertson 85 1133 1019 29 596 153
San Jacinto 134 755 599 22 1142 113
Trinity 74 575 482 19 624 70
Walker 302 6944 6837 99 2508 391
Waller 259 2973 2682 32 1346 230
Washington 125 1768 73 1826 254

The Texas State COVID-19 Dashboard has undergone some updates and has changed how they define numbers. Total cases is now the combination of confirmed cases and probable cases.

To view the state’s COVID-19 vaccine dashboard, click here.

For the latest updates from TDCJ, click here.

Texas A&M University

The Texas A&M COVID-19 Dashboard reported 70 new cases and 495 active cases on Jan. 27.

Currently, the university has reported 5,901 positive cases, 7.2 percent of tests have come back positive.

The dashboard’s last update was provided on Jan. 30, 2021.


[View the state’s coronavirus dashboard for the latest COVID-19 case information.]

[View the state’s COVID-19 vaccine dashboard]

Statewide, Texas has an estimated 363,090 active cases and 1,932,694 recoveries. There have been 2,349,262 total cases reported and 19,956,098 total tests (both viral and antibody).

To date, 36,320 Texans have died from COVID-19.

Currently, 1,109,874 Texans have been vaccinated with at least one dose of the COVID-19 vaccine and 166,934 Texans have been fully vaccinated. Across Texas, 1,723,675 doses have shipped.

254 of 254 counties in the state of Texas are currently reporting cases. Harris County leads the state in total cases with 311,665 cases reported.

The state’s last update was provided on January 30 at 1:05 p.m.

Editor’s note: Leon County updates their cases every Wednesday. KBTX uses the State Dashboard, which updates daily, for a more accurate reading of cases.

Copyright 2020 KBTX. All rights reserved.


Essential workers get lost in the vaccine scrum as states prioritize the elderly – The Washington Post

Please enable cookies on your web browser in order to continue.

The new European data protection law requires us to inform you of the following before you use our website:

We use cookies and other technologies to customize your experience, perform analytics and deliver personalized advertising on our sites, apps and newsletters and across the Internet based on your interests. By clicking “I agree” below, you consent to the use by us and our third-party partners of cookies and data gathered from your use of our platforms. See our Privacy Policy and Third Party Partners to learn more about the use of data and your rights. You also agree to our Terms of Service.


COVID-19 in South Dakota: 179 total new cases; Death toll rises to 1,778; Active cases at 2,833 –

Sorry, Readability was unable to parse this page for content.